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Background
Several studies have shown an increased risk of colorectal
and extracolonic cancers for carriers of germline MUTYH
mutations inherited from both parents (biallelic muta-
tions). Extracolonic cancer risks for carriers of a MUTYH
mutation inherited from only one parent (monoallelic
mutation) have not previously been estimated.
Materials and methods
We identified 144 families of MUTYH mutation carriers
from three countries that we ascertained through popula-
tion-based sources of the multi-site, international Colon
Cancer Family Registry. Mutation status, sex, age, and his-
tories of cancer, polypectomy, and hysterectomy were
sought from 2,179 of their relatives. Using Cox regression
weighted to adjust for the method of ascertainment, we
estimated the country-, age- and sex-specific standardized
incidence ratios (SIRs) of colorectal and extracolonic
cancers for monoallelic mutation carriers, compared with
the general population, and corresponding age-specific
cumulative risks.
Results
Monoallelic mutation carriers with a family history of CRC
had a significantly increased incidence of CRC (SIR = 2.04;
95% confidence interval, CI = 1.56 – 2.70; P <0.001), gastric
cancer (SIR = 3.24; 95% CI = 2.18 – 4.98; P <0.001), and
endometrial cancer (SIR = 2.23; 95% CI = 1.13 – 4.86; P =
0.03) and a marginal increased incidence of liver cancer
(SIR = 3.09; 95% CI = 1.07 – 12.25; P = 0.07) compared to
the general population. The estimated cumulative risks to
age 70 years based on the population cancer incidence of
the United States were as follows: for CRC, 6% (95% CI =
5 – %) for men and 4% (95% CI = 3 – 6%) for women; for
gastric cancer, 2% (95% CI = 1 – 3%) for men and 0.7%
(95% CI = 0.5 – 1%) for women; for liver cancer, 1% (95%
CI = 0.3 – 3%) for men and 0.3% (95% CI = 0.1 – 1%) for
women; and for endometrial cancer, 4% (95% CI = 2 –
8%). There was no evidence of increased risks for cancer of
the brain, pancreas, kidney, lung, breast or prostate.
Conclusion
Monoallelic MUTYH mutation carriers with a family
history of CRC are at increased risk of colorectal, gas-
tric, liver and endometrial cancers.
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